BCYC
Companies
NASDAQ
Bicycle Therapeutics PLC ADR
Health Care
$7.41
-$6.59 (-47.07%)
Price Chart
Overview
About BCYC
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC.
Market Cap
$1.6B
Volume
3.1M
Avg. Volume
2.5M
P/E Ratio
-1.8929577
Dividend Yield
0.00%
Employees
254.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.90
Moderate Correlation
Volatility
High (0.67)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
High Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, BCYC shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$1.6B
Volume3.1M
P/E Ratio-1.89
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
February 25, 2025Related Securities
Pricing info last updated June 18, 2025 (after market close)Other info last updated April 2, 2025